Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales still disappointed

Technicians agree on one thing: There’s more volatility ahead.

Baby boomers are poised to hit an already overburdened senior care space in the next few years. Investors are looking to buy up long-term and […]

The company is in the process of “winding down outdated programs and materials” as part of a broader review of hundreds of initiatives.